CIDEX Activated Dialdehyde Solution, 4 bottles/case, P/N: 2266
FDA Device Recall #Z-2459-2015 — Class II — July 27, 2015
Recall Summary
| Recall Number | Z-2459-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 27, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Advanced Sterilization Products |
| Location | Irvine, CA |
| Product Type | Devices |
| Quantity | 23,426 cases |
Product Description
CIDEX Activated Dialdehyde Solution, 4 bottles/case, P/N: 2266
Reason for Recall
Advanced Sterilization Products (ASP) is recalling the CIDEX Activated Dialdehyde Solution because it may lack the adequate data to support the entire 24-month shelf life.
Distribution Pattern
US (nationwide) Distribution
Lot / Code Information
210813065 210813066 220813066 230813067 270813067 270813068 270813069 280813069 280813070 290813070 021013082 031013082 031013083 031013084 041013084 071013084 071013085 111013090 111013091 141013091 231013091 241013091 241013092 281013093 060114109 070114109 290114001 300114001 300114002 100214003 100214004 110214004 130214004 010414020 010414021 250314017 260314017 260314018 270314018 270314019 310314019 310314020 070514029 120514029 120514030 130514030 140514030 010714048 300614047 020714048 020714049 030714049 090914066 100914066 110914066 110914067 150914067 160914068 170914068 170914069 021014077 231014084 231014085 271014085 271014086 281014086 201114092 211114092 091214099 091214100 150115006 160115006 220115006 220115007 230115007 100215012 110215012 110215013 050515029 050515030 060515030 070515031
Other Recalls from Advanced Sterilization Products
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1197-2017 | Class II | STERRAD NX Sterilization System, Product Code: ... | Jan 9, 2017 |
| Z-0965-2017 | Class II | EVOTECH Endoscope Cleaner and Reprocessor Syste... | Sep 27, 2016 |
| Z-2774-2015 | Class II | CIDEX OPA Solution, P/N 20390 for use as a high... | Aug 10, 2015 |
| Z-2375-2015 | Class II | Wall Chart for STERRAD 100NX System, P/N 10104.... | Jul 17, 2015 |
| Z-1715-2015 | Class II | EVOTECH Endoscope Cleaner and Reprocessing Syst... | May 11, 2015 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.